Liquid Biopsy Market: Increasing prevalence of cancer and rising demand for non-invasive procedures are key drivers for Global Liquid Biopsy Market.

Scope of Global Liquid Biopsy Market Reports –

Liquid Biopsy is a unique and non-invasive alternative tool to surgical biopsies and helps in determining an array of information about tumors through a simple test sample. According to the International Agency for Research on Cancer, by 2030 there will be over 22 million new cases a year, up from 14 million in 2012. There is a significant rise in prevalence of cancer globally. So, during the study of Global Liquid Biopsy market, we have considered Liquid Biopsy products and consumables to analyze the market.

Global Liquid Biopsy Market report is segmented on the basis of Product type, Biomarker type, Sample type, Application Type, End User type and by regional & country level. Based on Product type global Liquid Biopsy Market is classified as Instruments, Kits and Services. Based upon Biomarker, global Liquid Biopsy Market is classified as Cell-free DNAs (cfDNAs), Circulating tumor cells (CTCs) and Exosomes. Based upon Sample type, global Liquid Biopsy Market is classified as Blood, Urine, Serum/Plasma and others. Based upon Application type, global Liquid Biopsy Market is classified as Lung Cancer, Leukemia, Gastrointestinal Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer and others. Based upon End User type, global Liquid Biopsy Market is classified as Hospitals, Diagnostic Laboratories and Cancer Research Centers.

The regions covered in this Liquid Biopsy Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Liquid Biopsy is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for Global Liquid Biopsy Market Reports-

Global Liquid Biopsy market report covers prominent players like QIAGEN, Adaptive Biotechnologies, Johnson & Johnson, ANGLE plc, Biocept Inc., Bio-Rad Laboratories Inc., Cynvenio Biosystems, Inc., Epic Sciences, F. Hoffmann-La Roche Ltd., Genomic Health, Guardant Health, Inc., Illumina Inc., Janssen Diagnostics, MDxHealth, Menarini Silicon Biosystems, Myriad Genetics, Natera Inc., Pathway Genomics Corporation, NeoGenomics Laboratories, Inc., , RainDance Technologies, Inc., Silicon Biosystems, Thermo Fisher Scientific, Trovagene Inc., Sysmex Corporation and others.

Global Liquid Biopsy Market Dynamics –

Increasing number of cancer patients, improvements in diagnostic testing, advancements in immunotherapy and targeted approaches and rising demand of non-invasive diagnostic procedures and personalized medicine

Global Liquid Biopsy Market Regional Analysis –

North America dominates the market with highest market share due to increasing number of cancer incidences and increasing launch of new and advanced products. According to NCI (National Cancer Institute), Increasing prevalence of cancer and increased growth in research and development activities are majorly responsible on growth of Liquid Biopsy market in Europe. According to the  latest report by World Health Organization (WHO), Asia Pacific region anticipates to see a 70% increase in new cancer cases in the next two decades. Asia Pacific Liquid Biopsy Market is witnessed with strong growth rate majorly due high prevalence of cancer, increasing population, growing awareness regarding cure and treatment of cancer and government funding for research and development.

Key Benefits for Global Liquid Biopsy Market Reports –

Global Liquid Biopsy Market report covers in depth historical and forecast analysis.
Global Liquid Biopsy Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
Global Liquid Biopsy Market report helps to identify opportunities in market place.
Global Liquid Biopsy Market report covers extensive analysis of emerging trends and competitive landscape.
Liquid Biopsy Market Segmentation 
By Product Type

Instruments
Kits
Services
By Biomarker Type 

Cell-free DNAs (cfDNAs)
Circulating tumor cells (CTCs)
Exosomes
Others
By Sample Type 

Blood
Urine
Serum/Plasma
Others
By Application 

Lung Cancer
Leukemia
Gastrointestinal Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Others
 By End User

Hospitals
Diagnostic Laboratories
Cancer Research Centers
By Region

North America
U.S.
Mexico
Canada
Europe
UK
France
Germany
Italy
Asia Pacific
China
Japan
India
Southeast Asia
Latin America
Brazil
The Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Liquid Biopsy Market Key  Players
Qiagen
Adaptive Biotechnologies
Johnson & Johnson
Angle Plc.
Biocept Inc.
Bio-Rad Laboratories Inc.
Cynvenio Biosystems Inc.
Epic Sciences
Hoffmann-La Roche Ltd.
Genomic Health
Guardant Health Inc.